Model | Type III Analysis of Effects | Log Likelihood | p (Likelihood Ratio) | |
---|---|---|---|---|
1 | Factors | p | Â | Â |
 | Neoadjuvant therapy (D) | 0.0062 | -44.301 | 0.1568 |
 | Resection Margin positivity (R) | 0.0324 |  |  |
 | AJCC Stage IV vs. III or less (S) | 0.2256 |  |  |
 | D*R | 0.1649 |  |  |
2 | Neoadjuvant therapy (D) | 0.0569 | -45.294 | 0.8933 |
 | Resection Margin positivity (R) | 0.5757 |  |  |
 | AJCC Stage IV vs. III or less (S) | 0.1435 |  |  |
 | R*S | 0.8890 |  |  |
3 | Neoadjuvant therapy (D) | 0.6231 | -45.294 | 0.8933 |
 | Resection Margin positivity (R) | 0.1646 |  |  |
 | AJCC Stage IV vs. III or less (S) | 0.1423 |  |  |
 | D*S | 0.8890 |  |  |
4 | Neoadjuvant therapy (D) | 0.0955 | -44.232 | 0.5434 |
 | Resection Margin positivity (R) | 0.0974 |  |  |
 | AJCC Stage IV vs. III or less (S) | 0.1856 |  |  |
 | D*R | 0.1522 |  |  |
 | R*S | - |  |  |
 | S*D | - |  |  |